171 related articles for article (PubMed ID: 29544692)
1. [Cancer and venous thromboembolism recurrence: The keys for an optimal management].
Mahé I; Benhamou Y; Helfer H; Chidiac J
Bull Cancer; 2018 May; 105(5):508-516. PubMed ID: 29544692
[TBL] [Abstract][Full Text] [Related]
2. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
[TBL] [Abstract][Full Text] [Related]
3. [New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application].
Benzidia I; Connault J; Solanilla A; Michon-Pasturel U; Jamelot M; Nguessan MK; Hij A; Le Maignan C; Farge D; Frère C;
J Med Vasc; 2017 Dec; 42(6):375-383. PubMed ID: 29203044
[TBL] [Abstract][Full Text] [Related]
4. [Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?].
Debourdeau P; Cossou-Gbeto C; Takam-Sohwe T; Laroche JP
Bull Cancer; 2020 Feb; 107(2):224-233. PubMed ID: 32005356
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis.
Mahé I; Chidiac J; Helfer H; Noble S
J Thromb Haemost; 2016 Nov; 14(11):2107-2113. PubMed ID: 27566698
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of cancer-associated thrombosis in France: A national survey among vascular disease and supportive care specialists.
Mahé I; Scotté F; Rey JB; Elalamy I; Lamblin A; Mayeur D; Pernod G;
J Med Vasc; 2017 Oct; 42(5):255-262. PubMed ID: 28964384
[TBL] [Abstract][Full Text] [Related]
7. [Venous thrombo-embolic disease in cancer. Low molecular weight heparin indications].
Nou M; Laroche JP
J Mal Vasc; 2016 May; 41(3):197-204. PubMed ID: 27146099
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparins for cancer-associated thrombosis: Adherence to clinical practice guidelines and patient perception in TROPIQUE, a 409-patient prospective observational study.
Cajfinger F; Debourdeau P; Lamblin A; Benatar V; Falvo N; Benhamou Y; Sevestre MA; Farge-Bancel D;
Thromb Res; 2016 Aug; 144():85-92. PubMed ID: 27318244
[TBL] [Abstract][Full Text] [Related]
9. [Venous thromboembolic disease: Comparison of management practices in France, Italy and Spain].
Maurizot A; Bura-Rivière A; Gritli K; Bertoletti L; Hernández-Blasco L; Ciammaichella M; Díaz-Pedroche MC; Alfonso M; Lorente MA; Monreal M;
J Med Vasc; 2017 Feb; 42(1):6-13. PubMed ID: 28705449
[TBL] [Abstract][Full Text] [Related]
10. [Cancer-associated venous thromboembolic recurrence: disregard of treatment recommendations].
Mahé I; Chidiac J
Bull Cancer; 2014 Mar; 101(3):295-301. PubMed ID: 24691192
[TBL] [Abstract][Full Text] [Related]
11. Management of venous thromboembolism in cancer patients according to guidelines after educative measures.
Pillet A; Minne F; Belhadj Chaidi R; Chapelle G; Ferru A
Bull Cancer; 2018 May; 105(5):486-492. PubMed ID: 29680153
[TBL] [Abstract][Full Text] [Related]
12. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
13. Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.
Mahé I; Puget H; Buzzi JC; Lamuraglia M; Chidiac J; Strukov A; Helfer H; Perozziello A
Support Care Cancer; 2016 Aug; 24(8):3369-77. PubMed ID: 26984241
[TBL] [Abstract][Full Text] [Related]
14. LMWH in cancer patients with renal impairment - better than warfarin?
Bauersachs RM
Thromb Res; 2016 Apr; 140 Suppl 1():S160-4. PubMed ID: 27067971
[TBL] [Abstract][Full Text] [Related]
15. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
[TBL] [Abstract][Full Text] [Related]
16. [Venous thromboembolism and cancer].
Meyer G
Rev Pneumol Clin; 2014; 70(1-2):91-4. PubMed ID: 24566034
[TBL] [Abstract][Full Text] [Related]
17. [Adherence to guidelines for the treatment of venous thromboembolism in cancer patients: a retrospective analysis of 145 cases].
Belhadj Chaidi R; Thollot C; Ferru A; Roblot P; Landron C
J Mal Vasc; 2013 May; 38(3):185-92. PubMed ID: 23619202
[TBL] [Abstract][Full Text] [Related]
18. Management of Cancer-Associated Venous Thromboembolism in the Emergency Department.
Nene RV; Coyne CJ
Ann Emerg Med; 2017 Jun; 69(6):768-776. PubMed ID: 28169053
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
Khorana AA; Yannicelli D; McCrae KR; Milentijevic D; Crivera C; Nelson WW; Schein JR
Thromb Res; 2016 Sep; 145():51-3. PubMed ID: 27485998
[TBL] [Abstract][Full Text] [Related]
20. Management of recurrent venous thromboembolism in cancer patients.
Romualdi E; Ageno W
Thromb Res; 2016 Apr; 140 Suppl 1():S128-31. PubMed ID: 27067966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
